 | • レポートコード：GIR-203B16305 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 暴露前予防（PrEP）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の暴露前予防（PrEP）の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の暴露前予防（PrEP）の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 暴露前予防（PrEP）市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ツルバダ、創薬 用途別セグメントは次のように区分されます。 ・大人、青少年 世界の暴露前予防（PrEP）市場の主要な市場プレーヤーは以下のとおりです。 ・Gilead Sciences、Teva Pharmaceuticals、Strides Pharma Science、Lupin 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、暴露前予防（PrEP）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な暴露前予防（PrEP）メーカーの企業概要、2019年～2021年までの暴露前予防（PrEP）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な暴露前予防（PrEP）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別暴露前予防（PrEP）の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの暴露前予防（PrEP）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での暴露前予防（PrEP）市場予測を収録しています。 ・第12、13、14章では、暴露前予防（PrEP）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、Teva Pharmaceuticals、Strides Pharma Science、Lupin ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ツルバダ、創薬 ・用途別分析2016年-2026年：大人、青少年 ・暴露前予防（PrEP）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・暴露前予防（PrEP）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・暴露前予防（PrEP）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・暴露前予防（PrEP）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・暴露前予防（PrEP）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pre-Exposure Prophylaxis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pre-Exposure Prophylaxis size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Pre-Exposure Prophylaxis market size is expected to grow at a CAGR of % for the next five years.
Market segmentation
Pre-Exposure Prophylaxis market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Truvada
Discovy
Market segment by Application can be divided into
Adult
Adolescent
The key market players for global Pre-Exposure Prophylaxis market are listed below:
Gilead Sciences
Teva Pharmaceuticals
Strides Pharma Science
Lupin
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Pre-Exposure Prophylaxis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pre-Exposure Prophylaxis, with price, sales, revenue and global market share of Pre-Exposure Prophylaxis from 2019 to 2021.
Chapter 3, the Pre-Exposure Prophylaxis competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pre-Exposure Prophylaxis breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Pre-Exposure Prophylaxis market forecast, by regions, brand and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Pre-Exposure Prophylaxis sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Pre-Exposure Prophylaxis Introduction
1.2 Market Analysis by Brand
1.2.1 Overview: Global Pre-Exposure Prophylaxis Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Truvada
1.2.3 Discovy
1.3 Market Analysis by Application
1.3.1 Overview: Global Pre-Exposure Prophylaxis Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adult
1.3.3 Adolescent
1.4 Global Pre-Exposure Prophylaxis Market Size & Forecast
1.4.1 Global Pre-Exposure Prophylaxis Sales in Value (2016-2026))
1.4.2 Global Pre-Exposure Prophylaxis Sales in Volume (2016-2026)
1.4.3 Global Pre-Exposure Prophylaxis Price by Type (2016-2026) & (US$/Unit)
1.5 Global Pre-Exposure Prophylaxis Production Capacity Analysis
1.5.1 Global Pre-Exposure Prophylaxis Total Production Capacity (2016-2026)
1.5.2 Global Pre-Exposure Prophylaxis Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pre-Exposure Prophylaxis Market Drivers
1.6.2 Pre-Exposure Prophylaxis Market Restraints
1.6.3 Pre-Exposure Prophylaxis Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Pre-Exposure Prophylaxis Product and Services
2.1.4 Gilead Sciences Pre-Exposure Prophylaxis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business
2.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product and Services
2.2.4 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Strides Pharma Science
2.3.1 Strides Pharma Science Details
2.3.2 Strides Pharma Science Major Business
2.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Product and Services
2.3.4 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Lupin
2.4.1 Lupin Details
2.4.2 Lupin Major Business
2.4.3 Lupin Pre-Exposure Prophylaxis Product and Services
2.4.4 Lupin Pre-Exposure Prophylaxis Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Pre-Exposure Prophylaxis Sales by Manufacturer
3.1 Global Pre-Exposure Prophylaxis Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pre-Exposure Prophylaxis Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pre-Exposure Prophylaxis
3.4 Market Concentration Rate
3.4.1 Top 3 Pre-Exposure Prophylaxis Manufacturer Market Share
3.4.2 Top 6 Pre-Exposure Prophylaxis Manufacturer Market Share
3.5 Global Pre-Exposure Prophylaxis Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pre-Exposure Prophylaxis Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pre-Exposure Prophylaxis Market Size by Region
4.1.1 Global Pre-Exposure Prophylaxis Sales in Volume by Region (2016-2026)
4.1.2 Global Pre-Exposure Prophylaxis Revenue by Region (2016-2026)
4.2 North America Pre-Exposure Prophylaxis Revenue (2016-2026)
4.3 Europe Pre-Exposure Prophylaxis Revenue (2016-2026)
4.4 Asia-Pacific Pre-Exposure Prophylaxis Revenue (2016-2026)
4.5 South America Pre-Exposure Prophylaxis Revenue (2016-2026)
4.6 Middle East and Africa Pre-Exposure Prophylaxis Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pre-Exposure Prophylaxis Sales in Volume by Type (2016-2026)
5.2 Global Pre-Exposure Prophylaxis Revenue by Type (2016-2026)
5.3 Global Pre-Exposure Prophylaxis Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pre-Exposure Prophylaxis Sales in Volume by Application (2016-2026)
6.2 Global Pre-Exposure Prophylaxis Revenue by Application (2016-2026)
6.3 Global Pre-Exposure Prophylaxis Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pre-Exposure Prophylaxis Sales by Type (2016-2026)
7.2 North America Pre-Exposure Prophylaxis Sales by Application (2016-2026)
7.3 North America Pre-Exposure Prophylaxis Market Size by Country
7.3.1 North America Pre-Exposure Prophylaxis Sales in Volume by Country (2016-2026)
7.3.2 North America Pre-Exposure Prophylaxis Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pre-Exposure Prophylaxis Sales by Type (2016-2026)
8.2 Europe Pre-Exposure Prophylaxis Sales by Application (2016-2026)
8.3 Europe Pre-Exposure Prophylaxis Market Size by Country
8.3.1 Europe Pre-Exposure Prophylaxis Sales in Volume by Country (2016-2026)
8.3.2 Europe Pre-Exposure Prophylaxis Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pre-Exposure Prophylaxis Sales by Type (2016-2026)
9.2 Asia-Pacific Pre-Exposure Prophylaxis Sales by Application (2016-2026)
9.3 Asia-Pacific Pre-Exposure Prophylaxis Market Size by Region
9.3.1 Asia-Pacific Pre-Exposure Prophylaxis Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pre-Exposure Prophylaxis Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pre-Exposure Prophylaxis Sales by Type (2016-2026)
10.2 South America Pre-Exposure Prophylaxis Sales by Application (2016-2026)
10.3 South America Pre-Exposure Prophylaxis Market Size by Country
10.3.1 South America Pre-Exposure Prophylaxis Sales in Volume by Country (2016-2026)
10.3.2 South America Pre-Exposure Prophylaxis Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2016-2026)
11.2 Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2016-2026)
11.3 Middle East & Africa Pre-Exposure Prophylaxis Market Size by Country
11.3.1 Middle East & Africa Pre-Exposure Prophylaxis Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pre-Exposure Prophylaxis Typical Distributors
12.3 Pre-Exposure Prophylaxis Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pre-Exposure Prophylaxis Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pre-Exposure Prophylaxis Revenue by Application, (USD Million), 2021-2026
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Pre-Exposure Prophylaxis Product and Services
Table 6. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceuticals Major Business
Table 9. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product and Services
Table 10. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Strides Pharma Science Basic Information, Manufacturing Base and Competitors
Table 12. Strides Pharma Science Major Business
Table 13. Strides Pharma Science Pre-Exposure Prophylaxis Product and Services
Table 14. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Lupin Basic Information, Manufacturing Base and Competitors
Table 16. Lupin Major Business
Table 17. Lupin Pre-Exposure Prophylaxis Product and Services
Table 18. Lupin Pre-Exposure Prophylaxis Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Pre-Exposure Prophylaxis Sales by Manufacturer (2019-2021e) & (K Units)
Table 20. Global Pre-Exposure Prophylaxis Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Pre-Exposure Prophylaxis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Pre-Exposure Prophylaxis Production Capacity by Company, (K Units): 2020 VS 2021
Table 23. Head Office and Pre-Exposure Prophylaxis Production Site of Key Manufacturer
Table 24. Pre-Exposure Prophylaxis New Entrant and Capacity Expansion Plans
Table 25. Pre-Exposure Prophylaxis Mergers & Acquisitions in the Past Five Years
Table 26. Global Pre-Exposure Prophylaxis Sales by Region (2016-2021e) & (K Units)
Table 27. Global Pre-Exposure Prophylaxis Sales by Region (2021-2026) & (K Units)
Table 28. Global Pre-Exposure Prophylaxis Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Pre-Exposure Prophylaxis Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 31. Global Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 32. Global Pre-Exposure Prophylaxis Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Pre-Exposure Prophylaxis Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Pre-Exposure Prophylaxis Price by Type (2016-2021e) & (US$/Unit)
Table 35. Global Pre-Exposure Prophylaxis Price by Type (2021-2026) & (US$/Unit)
Table 36. Global Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 37. Global Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 38. Global Pre-Exposure Prophylaxis Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Pre-Exposure Prophylaxis Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Pre-Exposure Prophylaxis Price by Application (2016-2021e) & (US$/Unit)
Table 41. Global Pre-Exposure Prophylaxis Price by Application (2021-2026) & (US$/Unit)
Table 42. North America Pre-Exposure Prophylaxis Sales by Country (2016-2021e) & (K Units)
Table 43. North America Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units)
Table 44. North America Pre-Exposure Prophylaxis Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Pre-Exposure Prophylaxis Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 47. North America Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 48. North America Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 49. North America Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 50. Europe Pre-Exposure Prophylaxis Sales by Country (2016-2021e) & (K Units)
Table 51. Europe Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units)
Table 52. Europe Pre-Exposure Prophylaxis Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Pre-Exposure Prophylaxis Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 55. Europe Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 56. Europe Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 57. Europe Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 58. Asia-Pacific Pre-Exposure Prophylaxis Sales by Region (2016-2021e) & (K Units)
Table 59. Asia-Pacific Pre-Exposure Prophylaxis Sales by Region (2021-2026) & (K Units)
Table 60. Asia-Pacific Pre-Exposure Prophylaxis Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Pre-Exposure Prophylaxis Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 63. Asia-Pacific Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 64. Asia-Pacific Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 65. Asia-Pacific Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 66. South America Pre-Exposure Prophylaxis Sales by Country (2016-2021e) & (K Units)
Table 67. South America Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units)
Table 68. South America Pre-Exposure Prophylaxis Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Pre-Exposure Prophylaxis Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 71. South America Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 72. South America Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 73. South America Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 74. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2016-2021e) & (K Units)
Table 75. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2021-2026) & (K Units)
Table 76. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2016-2021e) & (K Units)
Table 79. Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2021-2026) & (K Units)
Table 80. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2016-2021e) & (K Units)
Table 81. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2021-2026) & (K Units)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Pre-Exposure Prophylaxis Typical Distributors
Table 85. Pre-Exposure Prophylaxis Typical Customers
List of Figures
Figure 1. Pre-Exposure Prophylaxis Picture
Figure 2. Global Pre-Exposure Prophylaxis Sales Market Share by Type in 2020
Figure 3. Truvada
Figure 4. Discovy
Figure 5. Global Pre-Exposure Prophylaxis Sales Market Share by Application in 2020
Figure 6. Adult
Figure 7. Adolescent
Figure 8. Global Pre-Exposure Prophylaxis Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Pre-Exposure Prophylaxis Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Pre-Exposure Prophylaxis Sales (2016-2026) & (K Units)
Figure 11. Global Pre-Exposure Prophylaxis Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Pre-Exposure Prophylaxis Production Capacity (2016-2026) & (K Units)
Figure 13. Global Pre-Exposure Prophylaxis Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Pre-Exposure Prophylaxis Market Drivers
Figure 15. Pre-Exposure Prophylaxis Market Restraints
Figure 16. Pre-Exposure Prophylaxis Market Trends
Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Manufacturer in 2020
Figure 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Manufacturer in 2020
Figure 19. Pre-Exposure Prophylaxis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Pre-Exposure Prophylaxis Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Pre-Exposure Prophylaxis Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Pre-Exposure Prophylaxis Sales Market Share by Region (2016-2026)
Figure 23. Global Pre-Exposure Prophylaxis Revenue Market Share by Region (2016-2026)
Figure 24. North America Pre-Exposure Prophylaxis Revenue (2016-2026) & (USD Million)
Figure 25. Europe Pre-Exposure Prophylaxis Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Pre-Exposure Prophylaxis Revenue (2016-2026) & (USD Million)
Figure 27. South America Pre-Exposure Prophylaxis Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Pre-Exposure Prophylaxis Revenue (2016-2026) & (USD Million)
Figure 29. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2016-2026)
Figure 30. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2016-2026)
Figure 31. Global Pre-Exposure Prophylaxis Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 33. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2016-2026)
Figure 34. Global Pre-Exposure Prophylaxis Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Pre-Exposure Prophylaxis Sales Market Share by Type (2016-2026)
Figure 36. North America Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 37. North America Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2026)
Figure 38. North America Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2026)
Figure 39. United States Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2016-2026)
Figure 43. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 44. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2026)
Figure 45. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2026)
Figure 46. Germany Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Pre-Exposure Prophylaxis Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Pre-Exposure Prophylaxis Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Pre-Exposure Prophylaxis Revenue Market Share by Region (2016-2026)
Figure 55. China Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Pre-Exposure Prophylaxis Sales Market Share by Type (2016-2026)
Figure 62. South America Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 63. South America Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2026)
Figure 64. South America Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Pre-Exposure Prophylaxis Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
小動物用X線照射装置のグローバル市場 2021年：企業別、地域別、種類・用途別 The X-ray Irradiator for Small Animals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…- ロードバイクライトのグローバル市場 2021年：企業別、地域別、種類・用途別 The Road Bicycle Light market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…
- ホーザリー（婦人・紳士）のグローバル市場 2021年：企業別、地域別、種類・用途別 The Hosiery (Women and Men) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- クリーム代替品のグローバル市場 2021年：企業別、地域別、種類・用途別 The Cream Substitute market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…
- ローリングミラーのグローバル市場 2021年：企業別、地域別、種類・用途別 The Rolling Mirrors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, re…